Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06295393 · ClinicalTrials.gov registry record
Renin Angiotensin Aldosterone System In Septic Kids
A clinical trial of Sepsis and Acute Kidney Injury Due to Sepsis, sponsored by Northwell Health.
- Recruiting
- Registry status
- 74
- Enrollment target
- 1
- Study location
NCT06295393: Recruiting study of Sepsis and Acute Kidney Injury Due to Sepsis, sponsored by Northwell Health.
NCT06295393 is a study of Sepsis and Acute Kidney Injury Due to Sepsis that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 74 participants, below the 6,564-participant average among 90 other Sepsis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06295393, a study of Sepsis and Acute Kidney Injury Due to Sepsis, is actively recruiting participants, sponsored by Northwell Health.
- RECRUITING
- Registry status
- 74 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective observational cohort study; pediatric sepsis vs. healthy pediatric subjects and pediatric sepsis with acute kidney injury (AKI) vs without AKI. Blood samples and renal ultrasound will be collected on sequential days for septic subject and one time for the healthy patients. Enzyme-linked immunosorbent assays (ELISA) with be run on serum plasma to compare the renin-angiotensin-aldosterone system (RAAS) between groups.
Conditions Studied
Study Locations (1)
New York
- Cohen Children's Medical Center - New Hyde Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2024-01-24 |
| Est. Completion | 2025-06-01 |
What NCT06295393 shows while recruiting
NCT06295393 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 6,564-participant average among 90 other Sepsis trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Sepsis appearing as the primary indexed condition, and to 0 interventions.
NCT06295393 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06295393 about?
NCT06295393 is a clinical study titled "Renin Angiotensin Aldosterone System In Septic Kids". Prospective observational cohort study; pediatric sepsis vs. healthy pediatric subjects and pediatric sepsis with acute kidney injury (AKI) vs without AKI. Blood samples and renal ultrasound will be collected on sequential days for septic subject and one time for the healthy patients. Enzyme-linke...
What is the current status of trial NCT06295393?
This trial is currently recruiting. The enrollment target is 74 participants. The study started on 2024-01-24. Estimated completion is 2025-06-01.
What conditions does trial NCT06295393 study?
This clinical trial studies the following conditions: Sepsis, Acute Kidney Injury Due to Sepsis, Acute Kidney Injury (Nontraumatic).
Who is sponsoring clinical trial NCT06295393?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06295393 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sepsis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06295393's enrollment target sits among peer trials
74 63rd of 90 higher than 28 of 90 other Sepsis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sepsis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The APS Phenotyping Study
RECRUITING
-
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial
RECRUITING · Phase 2
-
Early Versus Late Adjunctive Vasopressin in Septic Shock
RECRUITING · Phase 4
-
The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls
RECRUITING · NA
-
External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
RECRUITING · NA
-
Limited Versus Extended Trophic Feeding (LET-FEED) Trial
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI